1Tiemey T. Adjuvant chemotherapy for localized resectable soft tissue sarcoma of adults, in the Cochrane Database of systemic reviews [ J ]. Oxford, The Cochrane Library, 1999,12 : 1-30.
2Resnik E, Chambers SK, Carcangiu ML, et al. A phase Ⅱ study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed mullerian tumors (MMT) of the uterus. [ J ]. Gynecol Oncol, 1995,56:370-375.
3Sutton G, Brunettto VL, Kilgore L, et al. A phase Ⅲ trial of ifosfamide with or without cisplatin in carcinoma of the uterus: a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 2000, 79 : 147-153.
4Tutton G, Kauderen J, Carson LF, et al. Adjuvant ifosfamide and cisplatin in patients with completely resected stage Ⅰ or Ⅱ carcinosarcoma (mixed mesodermal tumors ) of the uterus: a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 2005, 96:630-634.
5Cartin JP, Blessing JA, Soper JT, et al. Paclitaxel in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study [J]. Gynecol Oncol, 2001,83:89-94.
6Gallup DG, Blessing JA, Andersen W, et al. Evaluation of paclitaxel in previously treated leiomyosareoma of the uterus : a GOG study [ J]. Gynecol Oncol, 2003, 89:48-51.
7Homesley HD, Filiaci V, Markman M. Phase Ⅲ trial of ifosfamide with or without paelitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group study[J]. J Clin Oncol, 2007,25(5) :526-31.
8Miller DS, Blsssing JA, Kilgore LC, et al. Phase Ⅱ trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomysarcomas : a Gynecologic Oncology Group study [ J]. Am J Clin Oncol,2000,23:355-357.
9Hensley ML, Venkatraman E, Maki RG, et al. Docetaxel plus gemcitabine is active in leiomyosarcoma: results of a phase Ⅱ trial(Abstract1408) [J]. Oncologist, 2001,6:335-338.
10Toma S, Tutti A, Viliani G, et al. Liposomal doxorubicin in advanced pretreated soft tissue sarcomas: a phase study of the Italian Sarcoma Group [ J ]. Anticancer Res, 2000, 20 : 485- 492.
